Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia
Status:
Completed
Trial end date:
2000-08-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die. Colony-stimulating factors such as leridistim and filgrastim
increase the number of immune cells found in bone marrow or peripheral blood and may help a
person's immune system recover from the side effects of chemotherapy.
PURPOSE: Randomized phase II trial to compare the effectiveness of leridistim with that of
filgrastim to reduce side effects in older patients who are receiving cytarabine and
daunorubicin for acute myeloid leukemia.